• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Endocrinology

Energy-reduced Mediterranean diet with increased physical activity may significantly reduce risk of type 2 diabetes

byAdrian WongandThomas Su
August 28, 2025
in Endocrinology
Reading Time: 3 mins read
Mediterranean diet may reduce age-related neurocognitive decline
Share on FacebookShare on Twitter

1. In this secondary analysis of a randomized controlled trial, physical activity paired with an ad libitum energy-reduced Mediterranean diet was associated with significantly reduced incidence of type 2 diabetes among adults with overweight or obesity and metabolic syndrome.

2. The intervention was also associated with greater improvements in diet adherence as well as larger reductions in body weight and waist circumference.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Most studies showing the effect of lifestyle modifications on type 2 diabetes (T2D) involve weight loss through an energy-reduced, low-fat diet alongside increased physical activity, but few trials have examined weight loss through a relatively high-fat diet. A previous study found that a Mediterranean diet supplemented with extra-virgin olive oil or mixed nuts was associated with lower diabetes incidence had only a modest effect on body weight. This study aimed to determine whether weight loss intervention combining an energy-reduced Mediterranean diet with increased physical activity may reduce T2D incidence among adults with overweight or obesity and metabolic syndrome. After six years of follow-up, the weight loss intervention was associated with a nearly one-third reduction in T2D risk compared with a control Mediterranean diet without energy reduction, with a greater effect being observed in men. Both groups had increased adherence to the diet over time, although improvement was significantly greater in the intervention group. Similarly, the number of participants in both groups who reached their targets for almost all food items increased over time, although improvement was significantly greater among intervention participants. The intervention group also saw larger increases in physical activity and larger reductions in body weight and waist circumference. The generalizability of this study is limited by self-reporting of dietary adherence and a single-blinded design. Nevertheless, these findings suggest that increased physical activity alongside an energy-reduction Mediterranean diet may be a sustainable intervention for reducing risk of T2D and controlling body weight.

Click to read this study in AIM

Relevant Reading: Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet: Results of the PREDIMED-Reus nutrition intervention randomized trial

RELATED REPORTS

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

In-Depth [randomized controlled trial]: This secondary analysis of the PREDIMED-Plus randomized controlled trial aimed to assess whether a weight loss intervention consisting of an ad libitum energy-reduced Mediterranean diet and increased physical activity may reduce T2D incidence. Participants were eligible if they were men aged 55 to 75 years or women aged 60 to 75 years, had a body mass index [BMI] ≥27 and <40 kg/m2, did not have documented cardiovascular disease or diabetes, and met at least 3 criteria for metabolic syndrome. The energy-reduced Mediterranean diet included a planned reduction of 600 kcal/day, with 35% to 40% of calories being derived from fat. This study included 4746 patients without T2D (mean age, 64.9 years [standard deviation {SD}, 4.9]; 50% women). During a median follow-up of 6.6 years (interquartile range [IQR], 6.0 to 7.1 years), 629 participants developed diabetes. After 6 years, the absolute adjusted risk difference for incident T2D between the intervention and control groups was -2.4% (95% CI, -3.1 to -1.8), yielding a relative risk reduction of 31% (95% CI, 18% to 41%) in the intervention group compared with the control group. Subgroup analyses showed no statistically significant interactions for age, educational level, BMI, waist-to-height ratio, or baseline glucose level; a statistically significant difference was only seen for sex, with men having a greater risk reduction than women (p = 0.035). The mean difference in the erMedDiet score, which measures adherence to the study diets, between the intervention and control groups was 2.2 (95% CI, 2.0 to 2.3; p < 0.001). Mean body weight change over 6 years was -3.3kg (95% CI, -3.4 to -3.1kg) in the intervention group and -0.6 kg (95% CI, -0.7 to -0.4kg) in the control group, representing weight reductions of 3.7% in intervention and 0.6% in control. Furthermore, change in mean waist circumference was -3.6 cm (95% CI, -3.8 to -3.3 cm) in the intervention group and -0.3 cm (95% CI, -0.4 to -0.1cm) in the control group. Overall, this study suggests that a weight loss intervention consisting of an ad libitum energy-reduced Mediterranean diet and increased physical activity may significantly reduce risk of T2D incidence while also improving other markers of overall metabolic health.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: diabetes mellitusexercisemediterranean dietmetabolic syndromephysical activitywaist circumferenceweight loss
Previous Post

Vepdegestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

Next Post

The Scan by 2 Minute Medicine®: Fall boosters, mosquitoes, skin awareness, and Hollywood healing

RelatedReports

Reduced gestational weight gain with lifestyle intervention
Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026
Increasing maternal BMI linked to higher risk of cerebral palsy
Endocrinology

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

August 31, 2026
Fatty liver disease may independently predict high-risk coronary disease
Cardiology

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

August 21, 2026
Surgery

Duodenal-jejunal bypass liners may improve glycemic control in patients with diabetes

July 16, 2026
Next Post
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: Fall boosters, mosquitoes, skin awareness, and Hollywood healing

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Switching to camizestrant after ESR1 mutation detection prolongs progression free survival in advanced breast cancer

Significant reduction in prostate screening rates after revised guidelines

Utility of long-term routine laboratory toxicity monitoring of immunomodulatory drugs in rheumatoid arthritis

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.